METTL3 inhibited the expression of LHPP and NKX3‐1 in an m6A‐YTHDF2‐dependent manner to further promote AKT phosphorylation‐induced tumour progression in prostate cancer (Figure 1). This evidence concerns the gene METTL3 and prostate carcinoma.